AzTrials
AzTrials

SleepNCT03590795

VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire)

An observational study of Sleep, run by Philips Respironics at 6 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sleep is an important contributing factor to people's health. However, over one third of the general population has sleep complaints, causing both health related problems, and economic impact. Many do not think their problem sleep is serious enough to consult a physician (primary care or sleep specialist). Read more about this study

Who is it for?
Ages 20 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Sleep
What is being tested?
Sleep survey
How many people
204 participants
Where
6 sitesUnited States
Study dates
19 Jun 2018to 7 Sep 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population will be those who are new patients to the sleep lab or those recruited from a central recruiter that may or may not have sleep issues.

Who may be able to join

  • Age: 20-75 years old.
  • Able to provide written informed consent
  • Able to read, write and speak English

Who cannot join

  • Has seen a sleep physician previously for formal clinical evaluation of a potential sleep problem.
  • Is being treated for any sleep disorder.
  • Has a major psychiatric disorder that is unstable at the time of evaluation.
  • Has a major medical condition likely to contribute to and thus to confound any sleep problem (congestive heart failure, severe Chronic Obstructive Pulmonary Disease (COPD), a pain syndrome, etc).

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • NeuroTrials Research Inc.

    Atlanta, Georgia, 30342

  • Sleep Disorders Center of Alabama

    Birmingham, Alabama, 35213

  • Center for Sleep and Wake Disorders

    Chevy Chase, Maryland, 20815

  • Florida Lung & Sleep Associates

    Lehigh Acres, Florida, 33971

  • Sleep Therapy and Research Center

    San Antonio, Texas, 78229

  • Clayton Sleep Institute

    St Louis, Missouri, 63143

Other trials in United States

About this study

Sleep is an important contributing factor to people's health. However, over one third of the general population has sleep complaints, causing both health related problems, and economic impact. Many do not think their problem sleep is serious enough to consult a physician (primary care or sleep specialist). For a selection of this population, self-tracking devices can be a solution, but these trackers are often activity based and therefore lacking in their capacity to give insight into underlying causes of poor quality sleep and daytime fatigue.

A new options for these confused sleeper is an online questionnaire, developed by Philips and Cooperative Research Center (CRC) for Alertness, Safety and Productivity Imagine a troubled sleeper awake at 3 am, they search "Why can't I sleep?" and find the survey. From there the user takes the sleep survey, which has the ability to assess their most likely sleep problem or problems from a list of seven sleep problem categories based upon their responses. At the end of the survey, participants will get information about which problem category they will fall into, and the level of certainty around that.

The purpose of the study is to determine the accuracy of the questionnaire in identifying the correct sleep problem when compared with the assessment of a sleep physician in a clinical sleep center. We hope to enroll 200 participants which was based upon an Initial power analyses were completed using pilot data, assuming accuracy rates of 70, 80, and 90% and a total sample size of 200. The intervals would be about ± 4.5% (for 90%) to ± 7% (for 70%). Participants will complete the survey, be blinded to the results, and then have a consultation with a sleep physician who will make an independent assessment.

Conditions
Sleep
Being tested
Sleep survey

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sleep surveyOther

    The Sleep survey was created by the Collaborative Research Center (CRC), a joint effort of the Australian Government, Academia and Industry [including Philips]).

Study groups in NCT03590795
Study groupRoleWhat they receive
Problem SleepersThose individuals that have self identified as having a unspecified sleep problem will take the sleep survey.
Receives: Other: Sleep survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary analysis will calculate the agreement between the physician's primary diagnosis (considered the gold standard) and the Sleep survey's primary classification

    The primary analysis will calculate the agreement between the physician's primary diagnosis (considered the gold standard) and the Sleep survey's primary classification. Percent agreement will be calculated for each sleep problem, and for the study sample as a whole, including the 95% confidence interval (CI).

    Measured: 1 day

Secondary outcomes (1)
  1. Percent agreement will be calculated to determine how often the survey includes the physician's primary diagnosis as one of its classifications.

    Percent agreement will be calculated to determine how often the survey includes the physician's primary diagnosis as one of its classifications. This will be calculated for each sleep problem, and for the study sample as a whole, including the 95% confidence interval.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2018
  2. Study start19 Jun 2018
  3. Primary completion7 Sep 2018
  4. Study completion7 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
204 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03590795
Sponsor's protocol ID
SRC-AI-SC-2018-10138
Status last verified
Sep 2018
First submitted
10 Jul 2018
Last updated
21 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data sets will be shared with academic institutions for development purposes

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep, run by Philips Respironics at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary analysis will calculate the agreement between the physician's primary diagnosis (considered the gold standard) and the Sleep survey's primary classification (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in